Thema: US74006W2070
PRAX, US74006W2070
amc-6295170_1920.jpg - Foto: THN
Praxis Precision Medicines stock sets November 12 Investor Day
Praxis Precision Medicines stock is entering a busy period of scheduled corporate updates. Management will focus on launch readiness for two programs under FDA review.
ad-hoc-news.de, heute 00:37 Uhr
PRAX, US74006W2070
PRAX stock: UBS starts coverage of Praxis Precision Medicines ...
Praxis reported second-quarter expenses of USD 96.90 million. Praxis Precision Medicines stock held USD 1.40 billion in cash on June 30, 2026.
ad-hoc-news.de, 23.10.26 02:57 Uhr
PRAX, US74006W2070
H.C. Wainwright keeps USD 1,201 target for Praxis Precision ...
A USD 706.00 target was set for PRAX stock on October 14, 2026. Q2 loss reached USD 83.72 million versus USD 71.13 million a year earlier.
ad-hoc-news.de, 16.10.26 00:48 Uhr
PRAX, US74006W2070
BTIG raised its target for Praxis Precision Medicines stock ...
BTIG maintained Buy for Praxis Precision Medicines stock on October 6, 2026. Q2 loss was USD 2.87 per share versus USD 3.67 consensus.
ad-hoc-news.de, 14.10.26 04:38 Uhr
PRAX, US74006W2070
Praxis Precision Medicines stock fell 1.21 percent as Q2 ...
Praxis Precision Medicines stock reported diluted EPS of USD -2.87 for Q2 2026, beating consensus by USD 0.80. Operating expenses reached USD 96.9 million.
ad-hoc-news.de, 07.10.26 05:42 Uhr
PRAX, US74006W2070
PRAX stock gained 3 percent as Praxis disclosed employee ...
PRAX stock was last at USD 295.51 on October 2, 2026, after Praxis granted 3,478 shares to 14 employees. Q2 adjusted loss per share beat consensus by USD 0.80.
ad-hoc-news.de, 05.10.26 09:19 Uhr
PRAX, US74006W2070
JonesTrading raises target for Praxis Precision Medicines ...
